| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $14.7M | — | +40.8% |
| SG&A Expense | $10.8M | — | +22.5% |
| Operating Income | -$25.5M | — | -32.4% |
| Pre-tax Income | -$24.2M | — | -38.9% |
| Income Tax | $0 | — | — |
| Net Income | -$24.2M | — | -38.9% |
| EPS (Basic) | -$0.22 | — | -15.8% |
| EPS (Diluted) | -$0.22 | — | -15.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $225.6M | +106.2% | +32.3% |
| Current Assets | $227.0M | +102.1% | +32.2% |
| Total Assets | $228.6M | +100.7% | +32.5% |
| Current Liabilities | $11.7M | -5.4% | -44.3% |
| Total Liabilities | $11.7M | -5.4% | -44.3% |
| Stockholders' Equity | $216.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$18.9M | — | -71.0% |
| Capital Expenditures | $13K | — | -73.5% |
| Investing Cash Flow | -$13K | — | +73.5% |
| Financing Cash Flow | $135.1M | — | +2507.0% |
| Free Cash Flow | -$18.9M | — | -70.4% |
| +56.9% |